These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 18980286)

  • 1. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.
    Gillison ML; Chaturvedi AK; Lowy DR
    Cancer; 2008 Nov; 113(10 Suppl):3036-46. PubMed ID: 18980286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
    Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
    Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year relative survival for human papillomavirus-associated cancer sites.
    Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
    Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
    Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
    J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancers attributable to human papillomavirus infection.
    Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
    Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
    Nygård M; Hansen BT; Dillner J; Munk C; Oddsson K; Tryggvadottir L; Hortlund M; Liaw KL; Dasbach EJ; Kjær SK
    PLoS One; 2014; 9(2):e88323. PubMed ID: 24505474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing HPV-associated cancer globally.
    Lowy DR; Schiller JT
    Cancer Prev Res (Phila); 2012 Jan; 5(1):18-23. PubMed ID: 22219162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
    Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
    Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
    Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
    Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J
    Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of human papillomavirus-associated cancers among persons with AIDS.
    Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
    J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of noncervical human papillomavirus disease in the United States.
    Hu D; Goldie S
    Am J Obstet Gynecol; 2008 May; 198(5):500.e1-7. PubMed ID: 18455524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
    Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
    Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
    JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.
    Wolf J; Kist LF; Pereira SB; Quessada MA; Petek H; Pille A; Maccari JG; Mutlaq MP; Nasi LA
    Rev Med Virol; 2024 May; 34(3):e2537. PubMed ID: 38666757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.
    Smith JS; Backes DM; Hoots BE; Kurman RJ; Pimenta JM
    Obstet Gynecol; 2009 Apr; 113(4):917-924. PubMed ID: 19305339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.